Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa (PUSHUP)
BrUOG 419 - Promoting Utilization and Safety of Hydroxyurea Using Precision in Africa (PUSHUP)
Sponsor: Brown University
A PHASE3 clinical study on Sickle Cell Anemia in Children and Sickle Cell Disease, this trial is actively recruiting participants. The trial is conducted by Brown University and has accumulated 16 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
16 versions recorded-
May 2025 — Present [monthly]
Recruiting PHASE3
-
Sep 2024 — May 2025 [monthly]
Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE3
-
May 2024 — Jul 2024 [monthly]
Recruiting PHASE3
-
Dec 2023 — May 2024 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
▶ Show 11 earlier versions
-
Nov 2023 — Dec 2023 [monthly]
Not Yet Recruiting PHASE3
-
Sep 2023 — Nov 2023 [monthly]
Not Yet Recruiting PHASE3
-
Jun 2023 — Sep 2023 [monthly]
Not Yet Recruiting PHASE3
-
May 2023 — Jun 2023 [monthly]
Not Yet Recruiting PHASE3
-
Mar 2023 — May 2023 [monthly]
Not Yet Recruiting PHASE3
-
Feb 2023 — Mar 2023 [monthly]
Not Yet Recruiting PHASE3
-
Dec 2022 — Feb 2023 [monthly]
Not Yet Recruiting PHASE3
-
Nov 2022 — Dec 2022 [monthly]
Not Yet Recruiting PHASE3
-
Jul 2022 — Nov 2022 [monthly]
Not Yet Recruiting PHASE3
Phase: PHASE1 → PHASE3
-
Jun 2022 — Jul 2022 [monthly]
Not Yet Recruiting PHASE1
-
Apr 2022 — Jun 2022 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Brown University
- National Heart, Lung, and Blood Institute (NHLBI)
- Novartis
For direct contact, visit the study record on ClinicalTrials.gov .